SEC Tracker
Get the app

Intelligent Bio Solutions INBS

Intelligent Bio Solutions reports $2.66 million net loss for fiscal Q1 2026

Intelligent Bio Solutions (INBS) filed a 10-Q with the SEC on Nov 10, 2026, 8:31 am ET. Source: the filing on SEC EDGAR.

Form
10-Q
Filed
Importance
Notable
  1. Revenue: $1.39 million for the three months ended Sep 30, 2026
  2. Net loss: $2.66 million for the three months ended Sep 30, 2026
  3. Diluted EPS: -$0.86 for the three months ended Sep 30, 2026
  4. Cash and equivalents: $5.93 million at Sep 30, 2026

Written from the 10-Q on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Going-concern warning repeated

“Accordingly, these factors raise substantial doubt about the Company's ability to continue as a going concern.”
In the notes to the financial statements. Read it in the filing 10-Q on EDGAR

Also in the prior 10-K (filed Aug 20, 2026). Prior report Prior on EDGAR

Quoted from the filing.

Get an email when Intelligent Bio Solutions files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.